HyperMed, Inc. Garners $4,000,000 New Funding

  • Feed Type
  • Date
    5/23/2008
  • Company Name
    HyperMed, Inc.
  • Mailing Address
    305 Second Avenue Waltham, MA 02451
  • Company Description
    HyperMed, Inc., the leader in applying hyperspectral technology to medical applications. HyperMed’s flagship diagnostic device, OxyVu-1™, received U.S. Food and Drug Administration (FDA) clearance in November, 2006 for use in assessing patients for poor tissue circulation including those with diabetic foot ulcers, leg pain or other symptoms of poor blood flow.
  • Website
    http://www.hypermed-inc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds will support ongoing marketing and sales of OxyVu, its lead product.
  • M&A Terms
  • Venture Investor
    GBP Capital

By posting a comment, you agree to our terms and conditions.